Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
FASEB J ; 31(6): 2709-2719, 2017 06.
Article in English | MEDLINE | ID: mdl-28292961

ABSTRACT

Month-season of birth (M-SOB) is a risk factor in multiple chronic diseases, including multiple sclerosis (MS), where the lowest and greatest risk of developing MS coincide with the lowest and highest birth rates, respectively. To determine whether M-SOB effects in such chronic diseases as MS can be experimentally modeled, we examined the effect of M-SOB on susceptibility of C57BL/6J mice to experimental autoimmune encephalomyelitis (EAE). As in MS, mice that were born during the M-SOB with the lowest birth rate were less susceptible to EAE than mice born during the M-SOB with the highest birth rate. We also show that the M-SOB effect on EAE susceptibility is associated with differential production of multiple cytokines/chemokines by neuroantigen-specific T cells that are known to play a role in EAE pathogenesis. Taken together, these results support the existence of an M-SOB effect that may reflect seasonally dependent developmental differences in adaptive immune responses to self-antigens independent of external stimuli, including exposure to sunlight and vitamin D. Moreover, our documentation of an M-SOB effect on EAE susceptibility in mice allows for modeling and detailed analysis of mechanisms that underlie the M-SOB effect in not only MS but in numerous other diseases in which M-SOB impacts susceptibility.-Reynolds, J. D., Case, L. K., Krementsov, D. N., Raza, A., Bartiss, R., Teuscher, C. Modeling month-season of birth as a risk factor in mouse models of chronic disease: from multiple sclerosis to autoimmune encephalomyelitis.


Subject(s)
Disease Susceptibility , Encephalitis , Hashimoto Disease , Multiple Sclerosis , Myelin-Oligodendrocyte Glycoprotein/toxicity , Animals , Birth Rate , Disease Models, Animal , Encephalitis/chemically induced , Hashimoto Disease/chemically induced , Mice , Mice, Inbred Strains , Multiple Sclerosis/etiology , Peptide Fragments/toxicity , Retrospective Studies , Risk Factors , Seasons
2.
J Leukoc Biol ; 101(2): 531-542, 2017 02.
Article in English | MEDLINE | ID: mdl-27630217

ABSTRACT

Respiratory infection with Francisella tularensis (Ft) is characterized by a muted, acute host response, followed by sepsis-like syndrome that results in death. Infection with Ft establishes a principally anti-inflammatory environment that subverts host-cell death programs to facilitate pathogen replication. Although the role of cytokines has been explored extensively, the role of eicosanoids in tularemia pathogenesis is not fully understood. Given that lipoxin A4 (LXA4) has anti-inflammatory properties, we investigated whether this lipid mediator affects host responses manifested early during infection. The addition of exogenous LXA4 inhibits PGE2 release by Ft-infected murine monocytes in vitro and diminishes apoptotic cell death. Tularemia pathogenesis was characterized in 5­lipoxygenase-deficient (Alox5-/-) mice that are incapable of generating LXA4 Increased release of proinflammatory cytokines and chemokines, as well as increased apoptosis, was observed in Alox5-/- mice as compared with their wild-type counterparts. Alox5-/- mice also exhibited elevated recruitment of neutrophils during the early phase of infection and increased resistance to lethal challenge. Conversely, administration of exogenous LXA4 to Alox5-/- mice made them more susceptible to infection thus mimicking wild-type animals. Taken together, our results suggest that 5-LO activity is a critical regulator of immunopathology observed during the acute phase of respiratory tularemia, regulating bacterial burden and neutrophil recruitment and production of proinflammatory modulators and increasing morbidity and mortality. These studies identify a detrimental role for the 5-LO-derived lipid mediator LXA4 in Ft-induced immunopathology. Targeting this pathway may have therapeutic benefit as an adjunct to treatment with antibiotics and conventional antimicrobial peptides, which often have limited efficacy against intracellular bacteria.


Subject(s)
Arachidonate 5-Lipoxygenase/metabolism , Immunity/drug effects , Lipoxins/pharmacology , Metabolome , Respiratory Tract Infections/immunology , Respiratory Tract Infections/microbiology , Tularemia/immunology , Acute Disease , Animals , Apoptosis/drug effects , Arachidonate 5-Lipoxygenase/deficiency , Bone Marrow Cells/drug effects , Bone Marrow Cells/pathology , Cell Death/drug effects , Chemokines/metabolism , Chronic Disease , Dinoprostone/metabolism , Disease Susceptibility , Down-Regulation/drug effects , Francisella tularensis/drug effects , Indoles/pharmacology , Inflammation Mediators/metabolism , Leukotriene B4/metabolism , Lipoxins/administration & dosage , Macrophages/drug effects , Macrophages/microbiology , Macrophages/pathology , Mice, Inbred C57BL , Organ Specificity/drug effects , Tularemia/microbiology , Tularemia/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...